FindTrial
Sign In

Development of 5G MR remote diagnosis and treatment system and its preliminary application in neurosurgery

Development of 5G MR remote diagnosis and treatment system and its preliminary application in neurosurgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100050223
Enrollment
Unknown
Registered
2021-08-22
Start date
2021-09-01
Completion date
Unknown
Last updated
2022-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Common diseases in neurosurgery

Interventions

experimental group:Remote diagnosis and treatment based on MR
control group:Nil

Sponsors

Hwa Mei Hospital, University of Chinese Academy of Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Common diseases in neurosurgery, see neurosurgery diagnosis and treatment routine for details; 2. Sign informed consent; 3. Surgical treatment or continuous drug treatment.

Exclusion criteria

Exclusion criteria: 1. Mental illness; 2. Severe cardiovascular disease; 3. Pregnant women.

Design outcomes

Primary

MeasureTime frame
GCS score;mRS score;—

Countries

China

Contacts

Public ContactLi Zhenzhu

Hwa Mei Hospital, University of Chinese Academy of Sciences

lizhenzhu1@sina.com+86 15550208856

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026